ClinicalTrialsFinder

Hepatocellular Carcinoma Recurrent Clinical Trials in Hong Kong

1 recruitingHong Kong, Hong Kong

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent
SCG Cell Therapy Pte. Ltd.46 enrolled6 locationsNCT05417932